Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,500 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multicenter retrospective study of nivolumab for recurrent/metastatic oral squamous cell carcinoma.
Yamakawa N, Umeda M, Yoshii Y, Mitsudo K, Noguchi M, Kusukawa J, Katakura A, Nakayama H, Sasaki M, Noguchi T, Ueda M, Bukawa H, Yagihara K, Horie A, Miyazaki A, Chikazu D, Tomihara K, Mishima K, Otsuru M, Asoda S, Fujiwara S, Ohyama Y, Kurita H, Kawamata H, Fukuda M, Shintani Y, Kobayashi T, Kanno T, Oh-Iwa I, Kawano K, Yamashita Y, Kobayashi W, Ohiro Y, Uzawa K, Ota Y, Kirita T. Yamakawa N, et al. Among authors: umeda m. Oral Dis. 2024 Mar;30(2):247-258. doi: 10.1111/odi.14471. Epub 2023 Jan 4. Oral Dis. 2024. PMID: 36519515
Multicenter Retrospective Study of Adjuvant Therapy for Patients with Pathologically Lymph Node-Positive Oral Squamous Cell Carcinoma: Analysis of Covariance Using Propensity Score.
Yanamoto S, Otsuru M, Ota Y, Okura M, Aikawa T, Kurita H, Kamata T, Kirita T, Yamakawa N, Ueda M, Yamashita T, Komori T, Shigeta T, Yokoo S, Ogawa M, Umeda M; Japan Oral Oncology Group. Yanamoto S, et al. Among authors: umeda m. Ann Surg Oncol. 2015 Dec;22 Suppl 3:S992-9. doi: 10.1245/s10434-015-4824-5. Epub 2015 Aug 20. Ann Surg Oncol. 2015. PMID: 26289809
Evaluation of oral care to prevent oral mucositis in estrogen receptor-positive metastatic breast cancer patients treated with everolimus (Oral Care-BC): randomized controlled phase III trial.
Niikura N, Ota Y, Hayashi N, Naito M, Kashiwabara K, Watanabe K, Yamashita T, Mukai H, Umeda M. Niikura N, et al. Among authors: umeda m. Jpn J Clin Oncol. 2016 Sep;46(9):879-82. doi: 10.1093/jjco/hyw077. Epub 2016 Jun 30. Jpn J Clin Oncol. 2016. PMID: 27365521 Clinical Trial.
Therapeutic implication of mTORC2 in oral squamous cell carcinoma.
Naruse T, Yanamoto S, Okuyama K, Yamashita K, Omori K, Nakao Y, Yamada SI, Umeda M. Naruse T, et al. Among authors: umeda m. Oral Oncol. 2017 Feb;65:23-32. doi: 10.1016/j.oraloncology.2016.12.012. Epub 2016 Dec 23. Oral Oncol. 2017. PMID: 28109464
1,500 results